hVIVO PLC's (LON:HVO) executive chairman Trevor Phillips tells Proactive London's Andrew Scott the business is now better positioned to be profitable next year.
The creator of pioneering human disease models based upon viral challenge generated revenues of £5.9mln in the six months ended June 30, up £1mln year-on-year, or 20%.
''There's a lot of demand, a lot of interest in what we do and we've also expanded our service offering ... which means we've got a broader base now of potential clients that could work with us''.
''The pipeline looks strong, the cost base has been brought down to a level where it's an acceptable level for the sort of revenues we expect to generate''.